No demonstration of benefit with hydralazine plus isosorbide dinitrate in heart failure

RECOVER-VITAL clinical trial finds no benefit of extended duration of PAXLOVID for Long COVID

A digital strategy helped patients with heart failure to receive proven medication

Novel drug shows promise in an early phase trial in heart failure